ENVB vs. MRNY
ENVB (Enveric Biosciences Inc) is a stock, while MRNY (YieldMax MRNA Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, ENVB returned -91.00% vs 74.19% for MRNY. At a 0.19 correlation, their price movements are largely independent.
Performance
ENVB vs. MRNY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -62.81% return, which is significantly lower than MRNY's 75.79% return.
ENVB
- 1D
- 1.50%
- 1M
- -38.91%
- YTD
- -62.81%
- 6M
- -71.09%
- 1Y
- -91.00%
- 3Y*
- -87.42%
- 5Y*
- -85.20%
- 10Y*
- -75.09%
MRNY
- 1D
- 1.61%
- 1M
- 20.79%
- YTD
- 75.79%
- 6M
- 62.11%
- 1Y
- 74.19%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ENVB vs. MRNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -62.81% | -94.37% | -72.43% | -29.35% |
MRNY YieldMax MRNA Option Income Strategy ETF | 75.79% | -35.72% | -59.32% | 18.27% |
Correlation
The correlation between ENVB and MRNY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Oct 24, 2023 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. MRNY — Risk / Return Rank
ENVB
MRNY
ENVB vs. MRNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and YieldMax MRNA Option Income Strategy ETF (MRNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVB | MRNY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.98 | ||
| Sortino ratioReturn per unit of downside risk | -3.34 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.26 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.98 | 2.37 | -3.35 |
| Martin ratioReturn relative to average drawdown | -1.34 | 4.58 | -5.92 |
Loading charts...
Drawdowns
ENVB vs. MRNY - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than MRNY's maximum drawdown of -82.15%. Use the drawdown chart below to compare losses from any high point for ENVB and MRNY.
Loading charts...
Drawdown Indicators
| ENVB | MRNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -82.15% | -17.85% |
Max Drawdown (1Y)Largest decline over 1 year | -92.64% | -31.53% | -61.11% |
Max Drawdown (3Y)Largest decline over 3 years | -99.81% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -62.99% | -37.01% |
Average DrawdownAverage peak-to-trough decline | -86.10% | -52.86% | -33.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 67.99% | 16.26% | +51.73% |
Volatility
ENVB vs. MRNY - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 21.90% compared to YieldMax MRNA Option Income Strategy ETF (MRNY) at 15.74%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than MRNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | MRNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.90% | 15.74% | +6.16% |
Volatility (6M)Calculated over the trailing 6-month period | 105.52% | 39.32% | +66.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 174.84% | 51.06% | +123.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 156.05% | 51.05% | +105.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 164.54% | 51.05% | +113.49% |
Dividends
ENVB vs. MRNY - Dividend Comparison
ENVB has not paid dividends to shareholders, while MRNY's dividend yield for the trailing twelve months is around 82.61%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% |
MRNY YieldMax MRNA Option Income Strategy ETF | 82.61% | 145.98% | 178.49% | 1.75% |
Frequently Asked Questions
ENVB and MRNY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.90%) compared to MRNY (15.74%). In terms of maximum drawdown, ENVB dropped -100.00% vs MRNY's -82.15%.
MRNY currently has the higher Sharpe Ratio (1.46 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and MRNY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer